Bristol-Myers Squibb
BMY
2,570 hedge funds and large institutions have $102B invested in Bristol-Myers Squibb in 2026 Q3 according to their latest regulatory filings, with 223 funds opening new positions, 1,034 increasing their positions, 976 reducing their positions, and 136 closing their positions.
64% more first-time investments, than exits
New positions opened: 223 | Existing positions closed: 136
6% more repeat investments, than reductions
Existing positions increased: 1,034 | Existing positions reduced: 976
1% more funds holding
Funds holding: 2,549 → 2,570 (+21)
2.5% less ownership
Funds ownership: 82.7% → 80.2% (-2.5%)
5% less funds holding in top 10
Funds holding in top 10: 21 → 20 (-1)
11% less call options, than puts
Call options by funds: $2.1B | Put options by funds: $2.36B
23% less capital inflows, than outflows
Capital inflows: $5.81B | Capital outflows: $7.58B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$760M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$394M |
| 3 |
Charles Schwab
San Francisco,
California
|
+$307M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$185M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$178M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$727M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$593M |
| 3 |
BlackRock
New York
|
-$425M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$367M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$264M |
BMY Hedge Fund Activity: Q3 2026 in Review
2,570 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q3 2026, worth a combined $102B — up 5% from $97.4B a quarter earlier.
Buyers outnumbered sellers: 223 funds opened new BMY positions and 136 closed out — a net gain of 87 holders — while 1,034 added to existing stakes and 976 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $760M. The largest seller was JP Morgan Chase, cutting an estimated $727M.
- 2,570 institutional investors held Bristol-Myers Squibb (BMY) as of Q3 2026, up from 2,549 in Q2 2026.
- Funds reported $102B of Bristol-Myers Squibb stock for Q3 2026, up 5% quarter-over-quarter.
- 223 funds opened new Bristol-Myers Squibb positions in Q3 2026 and 136 closed out, a net change of +87 holders.
- The largest Bristol-Myers Squibb buyer in Q3 2026 was Fidelity Investments, an estimated $760M added.
- The largest Bristol-Myers Squibb seller in Q3 2026 was JP Morgan Chase, an estimated $727M sold.
Based on aggregated 13F filings for Q3 2026.